About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
ResponsibilityBeing the largest Polish pharmaceutical company we want to help people to live a healthy life in a healthy world. Social responsibility is an integral part of the management strategy in our company.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
Agata Łapińska-Kołodzińska PresidentAn expert in the pharmaceutical industry, in which she has held a management position for 20 years. Head of numerous projects. Director of HCP Marketing Department at Polpharma.
Krzysztof Kurowski Vice PresidentOver 21 years of experience in the pharmaceutical industry, particularly in research and development. A pharmacist by education.
Beata Kamosińska MemberIn the pharmaceutical industry for over 20 years. She represents the Medical Department of Polpharma.
Marcin Lewandowski MemberRelationship and Content Expert. Doctoral student at the Faculty of Medicine of the Cardinal Stefan Wyszyński University in Warsaw. Graduate of the Faculty of Journalism and Political Science of the University of Warsaw. In Polpharma since 2010.
Daniela Piotrowska Director of Polpharma Scientific FoundationExpert with over ten years of experience in business organization management. Lawyer, graduate of postgraduate studies in management at the Warsaw School of Economics.
Grzegorz Kotowski Chairman of the Supervisory BoardOver ten years of experience in managerial positions in companies associated with Jerzy Starak. He is a legal advisor entered in the list of the District Chamber of Legal Advisors in Warsaw. He has been working at Polpharma for over 15 years.
Grzegorz Chełmicki Member of the Supervisory BoardMBA and ACCA graduate. He has been working in the pharmaceutical industry for 17 years. CFO for business operations at Polpharma.
Scientific Council prof. dr hab. Janina Stępińska, MD, PhD, President of the Scientific Council – internal medicine, cardiologistprof. dr hab. Edward Franek, MD, PhD – internal medicine, endocrinology, nephrologyprof. dr hab. Zbigniew Gaciong, MD, PhD – internal medicineprof. dr hab. Piotr Kuna, MD, PhD – internal diseases and allergologyprof. dr hab. Grzegorz Opolski, MD, PhD – internal medicine, cardiologistprof. dr hab. Adam Płaźnik, MD, PhD – neuroscience and neurochemistryprof. dr hab. Jarosław Reguła, MD, PhD – internal diseases and gastroenterologyprof. dr hab. Jerzy Szaflik, MD, PhD – ophthalmologyprof. dr hab. Mirosław Wielgoś, MD, PhD – gynecology and obstetrics, perinatologyprof. dr hab. Katarzyna Życińska, MD, PhD – internal medicine
Scientific Council of Honour prof. dr hab. Waldemar Banasiak, MD, PhD – cardiologyprof. dr hab. Stefan Chłopicki, MD, PhD – experimental pharmacology, Director of Jagiellonian Centre for Experimental Therapeuticsprof. dr hab. Grzegorz Grynkiewicz, MD, PhD – organic, medical and pharmaceutical chemistryprof. dr hab. Marek Jarema, MD, PhD – psychiatry dr Wojciech Kuźmierkiewiczprof. dr hab. Roman Lorenc, MD, PhD – medicine and biochemistryprof. dr hab. Edmund Przegialiński, MD, PhD – pharmacologyprof. dr hab. Jacek Rożniecki – neurologyprof. dr hab. Jacek Spławiński, MD, PhD – pharmacologyprof. dr hab. Cezary Szczylik, MD, PhD – oncologyprof. dr hab. med. Kazimierz Roszkowski-Śliż, MD, PhD – clinical oncologyprof. dr hab. Marian Zembala, MD, PhD – cardiac surgery and transplantology
